Home » Authors » Jim Stommen

Articles by Jim Stommen

McClellan sees CMS, industry partnering in innovation push

March 7, 2005

Panel: In order to avoid pitfalls, start reimbursement drive early

March 4, 2005

VivoMetrics monitors growing opportunities for LifeShirt

Jan. 6, 2005

VivoMetrics monitors growing opportunities for LifeShirt

Jan. 4, 2005

Growing convergence of technologies interests clinicians, industry

June 1, 2004

'Cautious Optimism' Replaces Gloom And Doom For Biotech

Jan. 13, 2003

'Cautious Optimism' Replaces Gloom And Doom For Biotech

Jan. 13, 2003

Innovative technologies from smaller cardio firms stir interest

March 1, 2002

It's no MIRACLE that new EP therapies are being ADOPTed

July 1, 2001

Big hitters, emerging firms tell their tales at Piper Jaffray gathering

March 1, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 10, 2025.
FDA clears path for Boston Sci’s Bolt IVL to challenge J&J’s Shockwave
BioWorld MedTech
Boston Scientific Corp.’s up to $664 million acquisition of Bolt Medical Inc. closed just days after Bolt secured U.S. FDA 520(k) clearance for its intravascular...
Biopharma exempt from US reciprocal tariffs, but not untouched
BioWorld
At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...
Remegen’s lupus drug surfaces with phase III myasthenia gravis data
BioWorld
Remegen Co. Ltd. emerged as a surprise challenger in the generalized myasthenia gravis space, unveiling positive phase III data of its China-approved lupus drug,...